Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York